BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 19696300)

  • 1. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
    Tozaki M; Fukuma E
    AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Kubo M; Tokunaga E; Yamamoto H; Honda H
    Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
    J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T.
    Bogner W; Pinker K; Zaric O; Baltzer P; Minarikova L; Porter D; Bago-Horvath Z; Dubsky P; Helbich TH; Trattnig S; Gruber S
    Radiology; 2015 Jan; 274(1):74-84. PubMed ID: 25341078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
    Partridge SC; Mullins CD; Kurland BF; Allain MD; DeMartini WB; Eby PR; Lehman CD
    AJR Am J Roentgenol; 2010 Jun; 194(6):1664-73. PubMed ID: 20489111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy.
    Bartella L; Thakur SB; Morris EA; Dershaw DD; Huang W; Chough E; Cruz MC; Liberman L
    Radiology; 2007 Oct; 245(1):80-7. PubMed ID: 17885182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL; Rahmat K; Rozalli FI; Mohd-Shah MN; Aziz YF; Yip CH; Vijayananthan A; Ng KH
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings.
    Woodhams R; Kakita S; Hata H; Iwabuchi K; Umeoka S; Mountford CE; Hatabu H
    AJR Am J Roentgenol; 2009 Jul; 193(1):260-6. PubMed ID: 19542422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MR imaging of the breast: comparison of apparent diffusion coefficient values of normal breast tissue with benign and malignant breast lesions.
    Orguc S; Basara I; Coskun T
    Singapore Med J; 2012 Nov; 53(11):737-43. PubMed ID: 23192501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging with fat suppression using short-tau inversion recovery: Clinical utility for diagnosis of breast lesions.
    Ouyang Z; Ouyang Y; Zhu M; Lu Y; Zhang Z; Shi J; Li X; Ren G
    Clin Radiol; 2014 Aug; 69(8):e337-44. PubMed ID: 24837698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of apparent diffusion coefficient and quantitative kinetic parameters for predicting additional malignancy in patients with newly diagnosed breast cancer.
    Yoo H; Shin HJ; Baek S; Cha JH; Kim H; Chae EY; Kim HH
    Magn Reson Imaging; 2014 Sep; 32(7):867-74. PubMed ID: 24907855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
    Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
    Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.